Home > Healthcare > Medical Devices > Medical Supplies > pessary market
Get a free sample of Pessary Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Pessary Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Several key trends, driven by technological advancements, patient preferences, and evolving healthcare delivery, are shaping the growth and development of the market:
The ring pessary segment held a 51.6% market share in 2024 due to its broad applicability for treating mild to moderate prolapse and stress urinary incontinence, making it suitable for a wide patient population.
The global pessary industry was valued at USD 447.5 million in 2024 and is projected to grow at a 4.8% CAGR from 2025 to 2034, driven by the increasing prevalence of pelvic organ prolapse and urinary incontinence.
The U.S. pessary market generated approximately USD 169.7 million in 2024, driven by the high prevalence of pelvic disorders and the demand for non-invasive treatment options for women.
Key players in the market include Artisan Medical, Bioteque America, Bliss GVS Pharma, Bray Group (Ethos Partners), Coloplast Group, Contiform International, CooperSurgical, Dr. Arabin, Integra Lifesciences, MedGyn Products, Novomed group (Gyneas), Panpac Medical, and Personal Medical.